Giant Biogene Holding Future Growth
Future criteria checks 6/6
Giant Biogene Holding is forecast to grow earnings and revenue by 22.9% and 25.4% per annum respectively. EPS is expected to grow by 21.8% per annum. Return on equity is forecast to be 32.7% in 3 years.
Key information
22.9%
Earnings growth rate
21.8%
EPS growth rate
Personal Products earnings growth | 18.9% |
Revenue growth rate | 25.4% |
Future return on equity | 32.7% |
Analyst coverage | Good |
Last updated | 07 Aug 2024 |
Recent future growth updates
Recent updates
Giant Biogene Holding Co., Ltd.'s (HKG:2367) Popularity With Investors Is Clear
Jul 01Is Giant Biogene Holding Co., Ltd. (HKG:2367) Trading At A 32% Discount?
Apr 17Investors Interested In Giant Biogene Holding Co., Ltd.'s (HKG:2367) Earnings
Mar 28Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next
Mar 27Do Giant Biogene Holding's (HKG:2367) Earnings Warrant Your Attention?
Dec 24A Look At The Intrinsic Value Of Giant Biogene Holding Co., Ltd. (HKG:2367)
Oct 30Giant Biogene Holding Co., Ltd.'s (HKG:2367) Share Price Matching Investor Opinion
Mar 28Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 7,803 | 2,931 | 2,473 | 3,017 | 13 |
12/31/2025 | 6,197 | 2,349 | 2,035 | 2,406 | 15 |
12/31/2024 | 4,816 | 1,847 | 1,450 | 1,843 | 15 |
12/31/2023 | 3,524 | 1,452 | 1,419 | 1,647 | N/A |
9/30/2023 | 3,255 | 1,252 | 1,218 | 1,480 | N/A |
6/30/2023 | 2,985 | 1,052 | 1,016 | 1,313 | N/A |
3/31/2023 | 2,675 | 874 | 897 | 1,122 | N/A |
12/31/2022 | 2,364 | 696 | 778 | 932 | N/A |
12/31/2021 | 1,552 | 809 | 617 | 692 | N/A |
12/31/2020 | 1,190 | 826 | 758 | 834 | N/A |
12/31/2019 | 957 | 552 | 571 | 656 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2367's forecast earnings growth (22.9% per year) is above the savings rate (2.3%).
Earnings vs Market: 2367's earnings (22.9% per year) are forecast to grow faster than the Hong Kong market (11.3% per year).
High Growth Earnings: 2367's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2367's revenue (25.4% per year) is forecast to grow faster than the Hong Kong market (7.4% per year).
High Growth Revenue: 2367's revenue (25.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2367's Return on Equity is forecast to be high in 3 years time (32.7%)